SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & Fulvestrant for Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC" | VuMedi

Integrity CE

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & Fulvestrant for Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"

By Integrity CE FEATURING Aditya Bardia

By Integrity CE FEATURING Aditya Bardia

0 views

January 26, 2024

Comments 3

Login to view comments. Click here to Login